Profiling cancer testis antigens in non–small-cell lung cancer
Dijana Djureinovic, Björn M. Hallström, Masafumi Horie et al. · JCI Insight · 2016
Cancer testis antigens (CTAs) are of clinical interest as biomarkers and present valuable targets for immunotherapy. To comprehensively characterize the CTA landscape of non-small-cell lung cancer (NSCLC), we compared RNAseq data from 199 NSCLC tissues to the normal transcriptome of 142 samples from 32 different normal organs. Of 232 CTAs currently annotated in the Caner Testis Database (CTdatabase), 96 were confirmed in NSCLC. To obtain an unbiased CTA profile of NSCLC, we applied stringent criteria on our RNAseq data set and defined 90 genes as CTAs, of which 55 genes were not annotated in the CTdatabase, thus representing potential new CTAs. Cluster analysis revealed that CTA expression is histology dependent and concurrent expression is common. IHC confirmed tissue-specific protein expression of selected new CTAs (TKTL1, TGIF2LX, VCX, and CXORF67). Furthermore, methylation was identified as a regulatory mechanism of CTA expression based on independent data from The Cancer Genome Atlas. The proposed prognostic impact of CTAs in lung cancer was not confirmed, neither in our RNAseq cohort nor in an independent meta-analysis of 1,117 NSCLC cases. In summary, we defined a set of 90 reliable CTAs, including information on protein expression, methylation, and survival association. The detailed RNAseq catalog can guide biomarker studies and efforts to identify targets for immunotherapeutic strategies.
Cited by 119 works. doi:10.1172/jci.insight.86837 Open-access PDF
Authors
- Dijana Djureinovic
- Björn M. Hallström
- Masafumi Horie
- Johanna Sofia Margareta Mattsson
- Linnéa La Fleur
- Linn Fagerberg
- Hans Brunnström
- Cecilia Lindskog
- Katrin Madjar
- Jörg Rahnenführer
- Simon Ekman
- Elisabeth Ståhle
- Hirsh Koyi
- Eva Brandén
- Karolina Edlund
- Jan Georg Hengstler
- Mats P. Lambe
- Akira Saito
- Johan Botling
- Fredrik Pontén
References
- Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
- Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation
- Modeling Survival Data: Extending the Cox Model
- Differential expression analysis for sequence count data
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
- Survival Analysis Techniques for Censored and Truncated Data
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
- Tissue-based map of the human proteome
- Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses